Log in

Avanos Medical Stock Forecast, Price & News

+1.10 (+3.31 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $34.32
50-Day Range
MA: $32.29
52-Week Range
Now: $34.32
Volume229,525 shs
Average Volume352,521 shs
Market Capitalization$1.64 billion
P/E RatioN/A
Dividend YieldN/A
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. The company also offers Game Read, a product for pain management and rehabilitation of patients recovering from orthopedic surgery or sports-related injuries; GRPro 2.1, a cold and compression therapy system; Med4Elite, a multi-modality therapy unit; ATX Wraps; and various product accessories. In addition, it sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and GAME READY brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Read More
Avanos Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.21 out of 5 stars

Industry, Sector and Symbol

Industry Surgical appliances & supplies



Sales & Book Value

Annual Sales$697.60 million
Cash Flow$1.88 per share
Book Value$26.40 per share


Net Income$-45,900,000.00


Market Cap$1.64 billion
Next Earnings Date11/3/2020 (Estimated)
+1.10 (+3.31 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AVNS News and Ratings via Email

Sign-up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Avanos Medical (NYSE:AVNS) Frequently Asked Questions

How has Avanos Medical's stock price been impacted by Coronavirus (COVID-19)?

Avanos Medical's stock was trading at $29.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AVNS shares have increased by 18.3% and is now trading at $34.32.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Avanos Medical?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Avanos Medical

When is Avanos Medical's next earnings date?

Avanos Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Avanos Medical

How were Avanos Medical's earnings last quarter?

Avanos Medical Inc (NYSE:AVNS) announced its quarterly earnings data on Tuesday, August, 4th. The company reported $0.13 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.10) by $0.23. The firm earned $163.70 million during the quarter, compared to analysts' expectations of $147.90 million. Avanos Medical had a negative net margin of 2.40% and a positive return on equity of 3.52%. The business's revenue was down 4.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.28 EPS.
View Avanos Medical's earnings history

What price target have analysts set for AVNS?

6 Wall Street analysts have issued 1 year price objectives for Avanos Medical's stock. Their forecasts range from $30.00 to $43.00. On average, they anticipate Avanos Medical's share price to reach $33.20 in the next twelve months. This suggests that the stock has a possible downside of 3.3%.
View analysts' price targets for Avanos Medical

Are investors shorting Avanos Medical?

Avanos Medical saw a decline in short interest during the month of August. As of August 14th, there was short interest totaling 2,010,000 shares, a decline of 16.3% from the July 30th total of 2,400,000 shares. Based on an average trading volume of 292,800 shares, the days-to-cover ratio is currently 6.9 days. Approximately 4.3% of the company's shares are sold short.
View Avanos Medical's Short Interest

Who are some of Avanos Medical's key competitors?

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly Clark (KMB), CVS Health (CVS), Honeywell International (HON), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), AT&T (T), Abbott Laboratories (ABT), Alibaba Group (BABA) and NVIDIA (NVDA).

Who are Avanos Medical's key executives?

Avanos Medical's management team includes the following people:
  • Mr. Joseph F. Woody, CEO & Director (Age 53)
  • Mr. John W. Wesley, Sr. VP of Legal & Gov. Relations (Age 60)
  • Mr. John R. Tushar, Pres of Global Franchises (Age 57)
  • Mr. Arjun Ranjan Sarker, Sr. VP of International (Age 53)
  • Mr. Warren J. MacHan, Sr. VP of Bus. Strategy & Interim CFO (Age 53)

What is Avanos Medical's stock symbol?

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Who are Avanos Medical's major shareholders?

Avanos Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.37%), Paradice Investment Management LLC (5.55%), Victory Capital Management Inc. (4.08%), Macquarie Group Ltd. (3.49%), Goldman Sachs Group Inc. (3.32%) and Bank of New York Mellon Corp (1.18%). Company insiders that own Avanos Medical stock include Gary Blackford, John W Wesley, Joseph Fralin Woody and Steven E Voskuil.
View institutional ownership trends for Avanos Medical

Which institutional investors are selling Avanos Medical stock?

AVNS stock was sold by a variety of institutional investors in the last quarter, including Cove Street Capital LLC, Vanguard Group Inc., Advisor Group Holdings Inc., Confluence Investment Management LLC, Prudential Financial Inc., Oppenheimer Asset Management Inc., Russell Investments Group Ltd., and Charles Schwab Investment Management Inc..
View insider buying and selling activity for Avanos Medical

Which institutional investors are buying Avanos Medical stock?

AVNS stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Neuberger Berman Group LLC, Goldman Sachs Group Inc., Macquarie Group Ltd., Paradice Investment Management LLC, Schonfeld Strategic Advisors LLC, Marshall Wace LLP, and Phocas Financial Corp.. Company insiders that have bought Avanos Medical stock in the last two years include Gary Blackford, John W Wesley, Joseph Fralin Woody, and Steven E Voskuil.
View insider buying and selling activity for Avanos Medical

How do I buy shares of Avanos Medical?

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Avanos Medical's stock price today?

One share of AVNS stock can currently be purchased for approximately $34.32.

How big of a company is Avanos Medical?

Avanos Medical has a market capitalization of $1.64 billion and generates $697.60 million in revenue each year. The company earns $-45,900,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.

What is Avanos Medical's official website?

The official website for Avanos Medical is avanos.com.

How can I contact Avanos Medical?

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.